- Home
- KRYS vs CHDN Comparison
KRYS vs CHDN Comparison
Compare KRYS & CHDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRYS | CHDN |
|---|---|---|
| Founded | 2015 | 1928 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.1B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | KRYS | CHDN |
|---|---|---|
| Price | $246.66 | $109.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $226.56 | $137.73 |
| AVG Volume (30 Days) | 289.5K | ★ 645.1K |
| Earning Date | 02-18-2026 | 02-18-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | ★ 275.72 | 0.29 |
| EPS | ★ 6.66 | 5.53 |
| Revenue | $373,164,000.00 | ★ $2,884,200,000.00 |
| Revenue This Year | $36.14 | $8.66 |
| Revenue Next Year | $41.80 | $3.70 |
| P/E Ratio | $37.43 | ★ $20.48 |
| Revenue Growth | ★ 54.51 | 7.97 |
| 52 Week Low | $122.80 | $85.58 |
| 52 Week High | $265.92 | $134.44 |
Technical Indicators
Market Signals| Indicator | KRYS | CHDN |
|---|---|---|
| Relative Strength Index (RSI) | 60.83 | 40.23 |
| Support Level | $235.61 | $109.52 |
| Resistance Level | $257.95 | $116.04 |
| Average True Range (ATR) | 7.62 | 2.30 |
| MACD | -1.55 | -1.02 |
| Stochastic Oscillator | 57.06 | 3.96 |
Price Performance
Historical ComparisonAbout KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About CHDN Churchill Downs Incorporated
Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, Wagering Services, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The Wagering Services segment includes the revenue and expenses from pari-mutuel wagers through TwinSpires, companies retail and online sports betting business and Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.